Literature DB >> 16044323

Bactericidal/permeability-increasing protein in lacrimal gland and in tears of healthy subjects.

Heikki Peuravuori1, Valtteri V Aho, Heikki J Aho, Yrjö Collan, K Matti Saari.   

Abstract

BACKGROUND: To determine the expression of bactericidal/permeability-increasing protein (BPI), a novel antimicrobial molecule, in the main lacrimal gland and its content in tears of young healthy subjects.
METHODS: BPI concentration of tears was measured in 42 healthy volunteers, 13 men and 29 women, with ages ranging from 22 to 30 (mean 24.7+/-2.1) years by a time-resolved fluoroimmunoassay (TR-FIA). Immunohistochemical analysis was made to localize BPI in lacrimal gland and conjunctiva of eight autopsied subjects, two men and six women, with the age range from 44 to 87 (mean 72.3+/-14.9) years. RESULT: The mean concentration of BPI in tears was 27.8+/-29.5 microg/l, and it decreased with an increase in tear flow rate (P<0.0001). There was no statistically significant difference in BPI content of tears between the genders. BPI was immunohistochemically seen in outer basal epithelial cells of intralobular and excretory ducts, squamous and basal cells of conjunctiva as well as faintly in myoepithelial cell layer of acini. The presence of BPI in the lacrimal gland and in the tear fluid was verified by Western blotting.
CONCLUSIONS: The results indicate that outer basal epithelial cells of lacrimal gland ducts contain BPI, which occurs in a relatively high concentration in tears. BPI may have a substantial antibacterial role in human tears.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044323     DOI: 10.1007/s00417-005-0062-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  24 in total

1.  Group IIA phospholipase A2 content of basal, nonstimulated and reflex tears.

Authors:  Valtteri V Aho; Timo J Nevalainen; K Matti Saari
Journal:  Curr Eye Res       Date:  2002-03       Impact factor: 2.424

2.  Immunoglobulins in tears.

Authors:  B H McClellan; C R Whitney; L P Newman; M R Allansmith
Journal:  Am J Ophthalmol       Date:  1973-07       Impact factor: 5.258

3.  Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.

Authors:  M Levin; P A Quint; B Goldstein; P Barton; J S Bradley; S D Shemie; T Yeh; S S Kim; D P Cafaro; P J Scannon; B P Giroir
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

4.  Synthesis of group II phospholipase A2 and lysozyme in lacrimal glands.

Authors:  H J Aho; K M Saari; M Kallajoki; T J Nevalainen
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-08       Impact factor: 4.799

5.  Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcome.

Authors:  E Rintala; H Peuravuori; K Pulkki; L M Voipio-Pulkki; T Nevalainen
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

6.  Group II phospholipase A2 content of tears in patients with senile cataract and primary open-angle glaucoma.

Authors:  V V Aho; T J Nevalainen; V Paavilainen; K M Saari
Journal:  Eur J Ophthalmol       Date:  2002 Jan-Feb       Impact factor: 2.597

7.  Diurnal variation in group IIa phospholipase A2 content in tears of contact lens wearers and normal controls.

Authors:  Valtteri V Aho; Ville Paavilainen; Timo J Nevalainen; Heikki Peuravuori; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-01-25       Impact factor: 3.117

8.  Secretion of group 2 phospholipase A2 by lacrimal glands.

Authors:  T J Nevalainen; H J Aho; H Peuravuori
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-02       Impact factor: 4.799

9.  SDS-Minigel electrophoresis of human tears. Effect of sample treatment on protein patterns.

Authors:  A Kuizenga; N J van Haeringen; A Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-02       Impact factor: 4.799

10.  Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein.

Authors:  J O Häggblom; A B Jokilammi-Siltanen; H Peuravuori; T J Nevalainen
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

View more
  7 in total

1.  Interaction of phospholipid transfer protein with human tear fluid mucins.

Authors:  Niko L Setälä; Juha M Holopainen; Jari Metso; Gebrenegus Yohannes; Jaakko Hiidenhovi; Leif C Andersson; Ove Eriksson; Alexandra Robciuc; Matti Jauhiainen
Journal:  J Lipid Res       Date:  2010-08-19       Impact factor: 5.922

Review 2.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

Review 3.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

4.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

5.  Human antimicrobial proteins in ear wax.

Authors:  M Schwaab; A Gurr; A Neumann; S Dazert; A Minovi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-06       Impact factor: 3.267

6.  Serum BPI as a novel biomarker in asthma.

Authors:  Chen Xingyuan; Qiu Chen
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-18       Impact factor: 3.406

7.  Pseudomonas aeruginosa Outer Membrane Vesicles Triggered by Human Mucosal Fluid and Lysozyme Can Prime Host Tissue Surfaces for Bacterial Adhesion.

Authors:  Matteo M E Metruccio; David J Evans; Manal M Gabriel; Jagath L Kadurugamuwa; Suzanne M J Fleiszig
Journal:  Front Microbiol       Date:  2016-06-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.